Mass rollout planned across Southern Africa for new HIV drug
Summary
A new HIV drug called Lenacapavir, which is given only twice a year, provides over 99% protection against HIV. After being approved, it will be widely distributed in Southern African countries with high rates of HIV/AIDS.Key Facts
- Lenacapavir is a preventive drug for HIV.
- It only needs to be taken twice a year.
- The drug offers more than 99% protection against HIV.
- It has completed research and clinical trials.
- The drug has been officially approved for use.
- Southern African countries including South Africa, Zambia, Eswatini, Zimbabwe, Lesotho, and Mozambique will receive the drug.
- This region is the most affected by HIV/AIDS globally.
- The large-scale rollout aims to reduce new HIV infections in these countries.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
